Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan M Winter

Showing results (111-120 of 174) with videos related to

Pageof 18
Sort By:
Surgery|August 21, 2023
Differences in the surgical management of early-stage hepatocellular carcinoma at minority versus non-minority-serving hospitalsMohamedraed Elshami, Lauryn Bailey, Richard S Hoehn, et al.
RNA Biology|June 29, 2013
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancerRichard A Burkhart, Danielle M Pineda, Saswati N Chand, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 1, 2021
Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-operatively managed stage II-III pancreatic adenocarcinomaKavin Sugumar, Jonathan J Hue, Jeffrey M Hardacre, et al.
Surgery|April 28, 2007
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancerTimothy M Pawlik, Ana L Gleisner, John L Cameron, et al.
Journal of the American College of Surgeons|February 11, 2015
A prospective, randomized, double-blind, placebo controlled trial on the efficacy of ethanol celiac plexus neurolysis in patients with operable pancreatic and periampullary adenocarcinomaHarish Lavu, Harry B Lengel, Naomi M Sell, et al.
The American Surgeon|August 12, 2021
Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreatic Adenocarcinoma Treated With Multiagent Neoadjuvant Chemotherapy in the Modern EraJonathan J Hue, Jennifer Dorth, Kavin Sugumar, et al.
Cancers|November 11, 2022
Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?Hanna H Kakish, Fasih Ali Ahmed, Mohamedraed Elshami, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2021
Black race is independently associated with underutilization of transplantation for clinical T1 hepatocellular carcinomaKavin Sugumar, Sarah C Markt, Jonathan J Hue, et al.
Rare Tumors|April 6, 2011
Resectable pancreatic small cell carcinomaJordan M Winter, Amol K Narang, Aaron S Mansfield, et al.
Annals of Surgical Oncology|April 9, 2021
Weight Loss as an Untapped Early Detection Marker in Pancreatic and Periampullary CancerJonathan J Hue, Kavin Sugumar, Ravi K Kyasaram, et al.
Pageof 18

Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
Surgery|August 21, 2023
Differences in the surgical management of early-stage hepatocellular carcinoma at minority versus non-minority-serving hospitalsMohamedraed Elshami, Lauryn Bailey, Richard S Hoehn, et al.
RNA Biology|June 29, 2013
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancerRichard A Burkhart, Danielle M Pineda, Saswati N Chand, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 1, 2021
Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-operatively managed stage II-III pancreatic adenocarcinomaKavin Sugumar, Jonathan J Hue, Jeffrey M Hardacre, et al.
Surgery|April 28, 2007
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancerTimothy M Pawlik, Ana L Gleisner, John L Cameron, et al.
Journal of the American College of Surgeons|February 11, 2015
A prospective, randomized, double-blind, placebo controlled trial on the efficacy of ethanol celiac plexus neurolysis in patients with operable pancreatic and periampullary adenocarcinomaHarish Lavu, Harry B Lengel, Naomi M Sell, et al.
The American Surgeon|August 12, 2021
Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreatic Adenocarcinoma Treated With Multiagent Neoadjuvant Chemotherapy in the Modern EraJonathan J Hue, Jennifer Dorth, Kavin Sugumar, et al.
Cancers|November 11, 2022
Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?Hanna H Kakish, Fasih Ali Ahmed, Mohamedraed Elshami, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2021
Black race is independently associated with underutilization of transplantation for clinical T1 hepatocellular carcinomaKavin Sugumar, Sarah C Markt, Jonathan J Hue, et al.
Rare Tumors|April 6, 2011
Resectable pancreatic small cell carcinomaJordan M Winter, Amol K Narang, Aaron S Mansfield, et al.
Annals of Surgical Oncology|April 9, 2021
Weight Loss as an Untapped Early Detection Marker in Pancreatic and Periampullary CancerJonathan J Hue, Kavin Sugumar, Ravi K Kyasaram, et al.
Pageof 18